ArticleHistology and histopathology2026

CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomy.

Elisabeth Dingendorf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.